Shareholders Hit Peregrine Pharma Over Exec Compensation
Peregrine Pharmaceuticals Inc. shareholders filed a class action Friday in Delaware against the company's board of directors and CEO alleging they gave themselves excessive compensation that included "spring-loaded" stock options granted...To view the full article, register now.
Already a subscriber? Click here to view full article